Successful methylprednisolone desensitization in a pediatric patient

Güvenir, H.; Mısırlıoğlu, Emine Dibek; Aydin, Fatma; Ece, Dilek; Çakar, Nilgün; Kocabaş, Can Naci

doi:10.1111/pai.12693

Cited by 4 publications

(2 citation statements)

References 5 publications

(2 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…DPTs have shown that patients often tolerate alternative GCs belonging to the same chemical group as the responsible GC 182,183 . Desensitization to methylprednisolone has been successfully performed 186,187 (Table 3).…”

Section: Anti‐cytokine/anti‐inflammatory Drugs Used For Mas/cytokine mentioning

confidence: 99%

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper

Gelincik

Brockow

Çelik

et al. 2020

Allergy

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID‐19), a respiratory tract infection caused by a novel human coronavirus, the severe acute respiratory syndrome coronavirus 2, leads to a wide spectrum of clinical manifestations ranging from asymptomatic cases to patients with mild and severe symptoms, with or without pneumonia. Given the huge influence caused by the overwhelming COVID‐19 pandemic affecting over three million people worldwide, a wide spectrum of drugs is considered for the treatment in the concept of repurposing and off‐label use. There is no knowledge about the diagnosis and clinical management of the drug hypersensitivity reactions that can potentially occur during the disease. This review brings together all the published information about the diagnosis and management of drug hypersensitivity reactions due to current and candidate off‐label drugs and highlights relevant recommendations. Furthermore, it gathers all the dermatologic manifestations reported during the disease for guiding the clinicians to establish a better differential diagnosis of drug hypersensitivity reactions in the course of the disease.

show abstract

Section: Anti‐cytokine/anti‐inflammatory Drugs Used For Mas/cytokine mentioning

confidence: 99%

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper

Gelincik

Brockow

Çelik

et al. 2020

Allergy

View full text Add to dashboard Cite

show abstract

“…DPTs have shown that patients often tolerate alternative GCs belonging to the same chemical group as the responsible GC (179,180). Desensitization to methylprednisolone has been successfully performed (183,184).…”

Section: Hypersensitivity Reactionsmentioning

confidence: 99%

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19

Gelincik

Brockow

Çelik

et al. 2020

Preprint

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by a novel human coronavirus, the severe acute respiratory syndrome coronavirus 2, leads to a wide spectrum of clinical manifestations ranging from asymptomatic cases to patients with mild and severe symptoms, with or without pneumonia. Given the huge influence caused by the overwhelming COVID-19 pandemic affecting over three million people worldwide, a wide spectrum of drugs is considered for the treatment in the concept of repurposing and off-label use. There is no knowledge about the diagnosis and clinical management of the drug hypersensitivity reactions that can potentially occur during the disease. This review brings together all the published information about the diagnosis and management of drug hypersensitivity reactions due to current and candidate off-label drugs and highlights relevant recommendations. Furthermore, it gathers all the dermatologic manifestations reported during the disease for guiding the clinicians to establish a better differential diagnosis of drug hypersensitivity reactions in the course of the disease.

show abstract

Methylprednisolone sodium succinate

2017

Reactions Weekly

View full text Add to dashboard Cite

Successful methylprednisolone desensitization in a pediatric patient

Cited by 4 publications

References 5 publications

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19

Methylprednisolone sodium succinate

Contact Info

Product

Resources

About